Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Upgrades HCP (HCP) to Overweight
-
Veracyte to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Verastem Oncology to Present at Upcoming Investor Conferences
-
Regulus to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Merus to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Merus to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Ra Medical Systems (RMED) IPO Opens 26% Higher
-
GW Pharma (GWPH) Last Box Checked Off With Best Possible DEA Rescheduling - Cantor
-
Novavax (NVAX) Phase 2 Failure Represents Significant Lost Opportunity - Cantor Fitzgerald
-
Veru, Inc. (VERU) Prices 7.14M Common Stock Offering at $1.40/Share
-
Veru Announces Pricing of Public Offering of Common Stock
-
WellCare Health Plans (WCG) Acquiring Aetna Part D Is A Positive - Cantor Fitzgerald
-
ANI Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Heron Therapeutics (HRTX) Defended at Cantor
-
Hamilton Zanze and Cantor Fitzgerald Acquire The Quarters at Towson Town Center Apartment Community Through Second Joint Venture
-
Endocyte to Present at Two Investor Conferences on October 2nd
-
Endocyte to Present at Two Investor Conferences on October 2nd
-
SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on October 2, 2018
-
Cantor Offers Thoughts On Teva Pharma (TEVA) Weakness
-
X4 Pharmaceuticals Appoints Adam Mostafa as Chief Financial Officer
-
Ra Medical Systems, Inc. (RMED) Prices 3.9M Share IPO at $17/Sh
-
Ra Medical Systems Announces Pricing of Initial Public Offering
-
MacroGenics Announces Participation in Two Upcoming Investor Conferences
-
Vanda Pharmaceuticals Announces Participation at Oppenheimer and Cantor Fitzgerald Fall 2018 Investor Conferences
-
MacroGenics Announces Participation in Two Upcoming Investor Conferences
-
Dova Pharmaceuticals to Present at Upcoming Investor Conferences
-
Dova Pharmaceuticals to Present at Upcoming Investor Conferences
-
Cantor Fitzgerald Starts CIGNA (CI) at Overweight
-
Curis to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Veru, Inc. (VERU) Announces Proposed Common Share Offering
-
Aldeyra Therapeutics (ALDX) Announces Proposed 5.25M Share Public Offering of Common Stock
-
HTG Molecular to Present a Corporate Overview at the Cantor Fitzgerald Global Healthcare Conference
-
Veru Announces Proposed Public Offering of Common Stock
-
Aldeyra Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
-
PolarityTE (PTE) Form 483 Observations 'Likely Minor' - Cantor Fitzgerald
-
Aldeyra Therapeutics (ALDX) PT Raised to 'Street High' $30 at Cantor Fitzgerald
-
PDL BioPharma to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
/C O R R E C T I O N -- Infinity Pharmaceuticals, Inc./
-
Infinity To Present At Cantor Fitzgerald Global Healthcare Conference
-
ChemoCentryx to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
-
Cerus to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
-
ChemoCentryx to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
-
Amarin (AMRN) Has Solid IP on Vascepa Despite Questions - Cantor Fitzgerald
-
Quotient Limited to Participate in the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Foamix Pharmaceuticals to Participate in the Cantor Fitzgerald Global Healthcare Conference
-
Intra-Cellular Therapies to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Ekso Bionics to Present at the Cantor Fitzgerald Global Healthcare Conference on October 3, 2018
-
Tarveda Therapeutics to Present at Cantor Fitzgerald 2018 Global Healthcare Conference
-
Quotient Limited to Participate in the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Cantor Fitzgerald Starts Evofem Biosciences Inc (EVFM) at Overweight

